🔎 Trials Near Me

Akèy › Kolit Ulseratif › Lwizyàn › New Orleans

Etid klinik pou Kolit Ulseratif nan New Orleans, LA

6 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan ak bò kote New Orleans (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Ap rekriteFaz 2
  • Site 035, Marrero · 4 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07012395

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

Ap rekriteFaz 2
  • Tulane University School of Medicine-Gastroenterology and Hepatology ( Site 1073), New Orleans
Laj 18 a 75 · Tout sèks · Mizajou Sep 28, 2026 · NCT07463183

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Ap rekriteFaz 4
  • Tulane University, New Orleans
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06095128

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • Tandem Clinical Research - Marrero - Site Number: 8400002, Marrero · 4 mi lwen
Laj 16 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT07184996

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Ap rekriteFaz 2
  • Mirador Therapeutics Selected Site, Marrero · 4 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

Ap rekriteEtid obsèvasyon
  • Tulane University, New Orleans
Laj 18 ak plis · Tout sèks · Mizajou May 8, 2025 · NCT06750731

Etid Kolit Ulseratif nan lòt vil

Lòt etid nan New Orleans

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.